Regarding the other risk factors associated with the survival of advanced GIST patients treated with TKIs, such as ECOG PS score, age, sex, baseline neutrophil count, and baseline albumin level [5, 13, 20, 36], we could not identify their prognostic role after multivariate analysis. This evidence concerns the gene ALB and gastrointestinal stromal tumor.